Relationship between baseline clinical characteristics and efficacy of lusutrombopag in thrombocytopenic patients with chronic liver disease: post hoc analysis of two placebo-controlled phase 3 trials.

Katsuaki TanakaTakamichi BabaManami YoshidaMotofumi IguchiTakuhiro SonoyamaTakahiro FukuharaTakeshi Kano

Published in: Current medical research and opinion (2021)

analysis revealed a possible association between baseline WBC count and platelet count increase after lusutrombopag treatment. WBC count could be a relevant factor for lusutrombopag efficacy.

Keyphrases

peripheral blood
placebo controlled
single cell
clinical trial
squamous cell carcinoma
radiation therapy
phase ii
rectal cancer
replacement therapy